| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |